LONG-TERM PHOSPHODIESTERASE-5 INHIBITOR THERAPY PREVENTING PRIAPISM RECURRENCES

被引：0
|
作者：
Nardozza, Archimedes, Jr.
Coelho, Mariana Andrade
Oliveira, Frederico V.
Kobaz, Alberto K.
Alarcon, Gustavo
Offerni, Juliano C. M.
Cabrini, Marcelo R.
Ortiz, Valdemar
机构：
来源：
JOURNAL OF UROLOGY | 2009年 / 181卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(09)61492-0
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1478
引用
收藏
页码：528 / 529
页数：2
相关论文
共 50 条
  • [1] Long-term oral phosphodiesterase-5 inhibitor therapy alleviates recurrent priapism
    Burnett, AL
    Bivalacqua, TJ
    Champion, HC
    Musicki, B
    JOURNAL OF UROLOGY, 2006, 175 (04): : 301 - 301
  • [2] Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism
    Burnett, AL
    Bivalacqua, TJ
    Champion, HC
    Musicki, B
    UROLOGY, 2006, 67 (05) : 1043 - 1048
  • [3] Effect of long-term phosphodiesterase-5 inhibitor use on refractory lymphatic malformations in adult and teen patients
    Nelson, Kari J.
    Antiquera, Pamela
    Nelson, J. Stuart
    Kelly, Kristen M.
    Abi-Jaoudeh, Nadine
    JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS, 2021, 9 (01) : 258 - 261
  • [4] The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy
    N Mehrotra
    M Gupta
    A Kovar
    B Meibohm
    International Journal of Impotence Research, 2007, 19 : 253 - 264
  • [5] Effectiveness of phosphodiesterase-5 inhibitor therapy for portopulmonary hypertension
    Fisher, Jolene H.
    Johnson, Sindhu R.
    BMath, Cathy Chau
    Kron, Amie T.
    Granton, John T.
    CANADIAN RESPIRATORY JOURNAL, 2015, 22 (01) : 42 - 46
  • [6] The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy
    Mehrotra, N.
    Gupta, M.
    Kovar, A.
    Meibohm, B.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2007, 19 (03) : 253 - 264
  • [7] Effect of phosphodiesterase-5 inhibitor on hearing
    Okuyucu, S.
    Guven, O. E.
    Akoglu, E.
    Ucar, E.
    Dagli, S.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2009, 123 (07): : 718 - 722
  • [8] Long-term tolerability of phosphodiesterase-5 inhibitors in pulmonary hypertension of sickle cell disease
    Cramer-Bour, Cassondra
    Ruhl, Amy Parker
    Nouraie, Seyed Mehdi
    Emeh, Robert O.
    Ruopp, Nicole F.
    Thein, Swee Lay
    Weir, Nargues A.
    Klings, Elizabeth S.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (01) : 54 - 62
  • [9] Combination therapy with bosentan and phosphodiesterase-5 inhibitor in pulmonary arterial hypertension
    Morice, AH
    Mulrennan, S
    Clark, A
    EUROPEAN RESPIRATORY JOURNAL, 2005, 26 (01) : 180 - 180
  • [10] Longitudinal recovery patterns of penile length and the underexplored benefit of long-term phosphodiesterase-5 inhibitor use after radical prostatectomy
    Kwon, Young Suk
    Farber, Nicholas
    Yu, Ji Woong
    Rhee, Kevin
    Han, Christopher
    Ney, Patrick
    Hong, Jeong Hee
    Lee, Paul
    Gupta, Nikhil
    Kim, Wun-Jae
    Kim, Isaac Yi
    BMC UROLOGY, 2018, 18
12345